Renaissance Technologies’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43.1K Sell
22,100
-422,000
-95% -$823K ﹤0.01% 3413
2025
Q1
$782K Sell
444,100
-122,700
-22% -$216K ﹤0.01% 2549
2024
Q4
$1.51M Sell
566,800
-462,200
-45% -$1.23M ﹤0.01% 2233
2024
Q3
$2.36M Buy
1,029,000
+268,000
+35% +$614K ﹤0.01% 1910
2024
Q2
$2.22M Sell
761,000
-213,700
-22% -$624K ﹤0.01% 1822
2024
Q1
$3.55M Sell
974,700
-508,431
-34% -$1.85M 0.01% 1640
2023
Q4
$2.24M Buy
1,483,131
+1,093,131
+280% +$1.65M ﹤0.01% 1879
2023
Q3
$523K Buy
390,000
+78,100
+25% +$105K ﹤0.01% 2691
2023
Q2
$561K Buy
311,900
+38,800
+14% +$69.8K ﹤0.01% 2812
2023
Q1
$453K Buy
273,100
+128,900
+89% +$214K ﹤0.01% 2935
2022
Q4
$277K Sell
144,200
-116,315
-45% -$223K ﹤0.01% 3261
2022
Q3
$584K Buy
260,515
+174,215
+202% +$391K ﹤0.01% 2837
2022
Q2
$280K Sell
86,300
-5,900
-6% -$19.1K ﹤0.01% 3494
2022
Q1
$485K Buy
92,200
+42,600
+86% +$224K ﹤0.01% 3217
2021
Q4
$422K Sell
49,600
-800
-2% -$6.81K ﹤0.01% 3159
2021
Q3
$501K Sell
50,400
-416,400
-89% -$4.14M ﹤0.01% 2892
2021
Q2
$4.35M Buy
+466,800
New +$4.35M 0.01% 1716